This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Partnering, Business Development & Licensing
search
Biz Dev/Licensing

Digimed and diagnostics: Market access and new collaborations

Posted by on 15 July 2017
Share this article

The effect of digital medicine on diagnostics is having and will continue to have a revolutionary effect on the interactions between patients and their healthcare providers and between the healthcare system and its service and support providers. While these changes herald more streamlined and to some extent personalized treatments for patients, the dynamic of these relationships will also have profound effects on treatment decisions. We examine the factors digital medicine companies face in gaining market access.


Moderator: Josep Sanfeliu – Ysios Capital
Michäel Herman – OncoDNA
Jeremy Sohn – Novartis
Gregg Talbert – Roche Partnering

Share this article

Sign up for Partnering, Business Development & Licensing email updates

keyboard_arrow_down